# Time to Eugonadal Range, Time to Steady State and Drying Time

> **NCT01228071** · PHASE3 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 34 (actual)

## Conditions studied

- Male Hypogonadism

## Interventions

- **DRUG:** testosterone gel 2%

## Key facts

- **NCT ID:** NCT01228071
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01228071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01228071, "Time to Eugonadal Range, Time to Steady State and Drying Time". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01228071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*